Angelova PR,Abramov AY .2018 .Role of mitochondrial ROS in the brain: From physiology to neurodegeneration. FEBS Lett, 592(5) : 692-702.
Bartus RT,Pt B .2017 .Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next? Neurobiol. , 97 : 169-178.
Bueno-Nava A,Gonzalez-Pina R,Alfaro-Rodriguez A,Nekrassov-Protasova V,Durand-Rivera A,Montes S,Ayala-Guerrero F .2010 .Recovery of motor deficit, cerebellar serotonin and lipid peroxidation levels in the cortex of injured rats. Neurochem. Res., 35(10) : 1538-1545.
Cheema MAR,Nawaz S,Gul S,Salman T,Naqvi S,Dar A,Haleem DJ A .2018 .Neurochemical and behavioral effects of Nigella sativa and Olea europaea oil in rats. Nutr, 21(3) : 185-194.
Deleu D,Northway MG,Hanssens Y .2002 .Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.. , : .
. .. Clin. Pharmacokinet, 41(4) : 261-309.
Pak. J. Pharm. Sci. .2000 .Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. JAMA, 284(15) : 1931-1938.
Hirtz D,Thurman D,Gwinn-Hardy K,Mohamed M,Chaudhuri A,Zalutsky R .2007 .How common are the “common” neurologic disorders?. Neurology, 68(5) : 326-337.
Holloway R,Shoulson I,Fahn S,Kieburtz K,Lang A,Marek K,Mcdermott M,Seibyl J,Weiner W,Musch B .2004 .Pramipexole vs levodopa as initial treatment for Parkinson disease: A 4-year randomized controlled trial. Arch Neurol, 61(7) : 1044-1053.
Hutter-Saunders JA,Gendelman HE,Mosley RL .2012 .- tetrahydropyridine (MPTP) intoxication. -phenyl-1, (3) : .
Pharmacol Neuroimmune . .. , 7(1) : 279-288.
Jin F,Wu Q,Lu YF,Gong QH,Shi JS .2008 .. , : .
. .Neuroprotective effect of resveratrol on 6-OHDAinduced Parkinson's disease in rats. Eur. J. Pharmacol., 600(1-3) : 78-82.
Jomova K,Vondrakova D,Lawson M,Valko M M .2010 .Metals, oxidative stress and neurodegenerative disorders. Mol. Cell Biochem, 345(1-2) : 91-104.
Khadrawy YA,Salem AM,El-Shamy KA,Ahmed EK,Fadl NN,Hosny EN .2017 .Neuroprotective and therapeutic effect of caffeine on the rat model of Parkinson's disease induced by rotenone. J. of Diet., : .
Suppl. . .. , 14(5) : 553-572.
Kim GH,Kim JE,Rhie SJ,Yoon S SJ .2015 .The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol, 24(4) : 325-340.
Lundblad M,Vaudano E,Cenci M .2003 .Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia. J. Neurochem., 84(6) : 1398-1410.
Mccarty MF,Dinicolantonio JJ .2016 .Lauric acidrich medium-chain triglycerides can substitute for other oils in cooking applications and may have limited pathogenicity. Open Heart, 3(2) : e000467.
Montgomery SL,Bowers WJ .2012 .Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol, 7(1) : 42-59.
Mumme K and Stonehouse W .2015 .Effects of mediumchain triglycerides on weight loss and body composition: A meta-analysis of randomized controlled trials. J, Acad, Nutr, 115(2) : 249-263.
Phatnani H and Maniatis T .2015 .Astrocytes in neurodegenerative disease. Cold Spring Harb Perspect Biol, 7 : a020628.
Ruiz-Larrea MB,Leal AM,Liza M,Lacort M and De Groot H M .1994 .Antioxidant effects of estradiol and 2- hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids, 59(6) : 383-388.
Salamone JD,Correa M .2002 .Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. , : .
Behav. Brain. Res. . .. , 137(1-2) : 3-25.
Shin HW,Chung SJ .2012 .Drug-induced parkinsonism. J. Clinic. Neuro., 8(1) : 15-21.
Tang J,Hu ZY,Chen XW .2007 .Free radical scavenging and antioxidant enzymes activation of polysaccharide extract from Nostoc sphaeroides. , : .
. .. of Chin. Med, 35(05) : 887-896.
Tansey MG,Goldberg MS .2010 .Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis, 37(3) : 510-518.
Valenti O,Gill KM,Grace AA .2012 .Different stressors produce excitation or inhibition of mesolimbic dopamine neuron activity: Response alteration by stress pre-exposure. Eur. J. Neurosci., 35(8) : 1312-1321.
Zaidi AA,Shakir L,Khan TA,Khan MA,Ali A,Rehman AU .2016 .Haloperidol leads to torse de pointes in schizophrenic pool. E. J. of Pharma. A Med, : .
Res . .. , 3(10) : 84-91.